Neochromosome, Inc

Becton, Dickinson & Company is a medical technology firm that serves health care institutions, life science researchers, clinical laboratories, industry and the general public. The organization manufactures and markets a broad range of medical supplies, devices, laboratory equipment and diagnostic products. In addition, the company focuses on building high value technologies for the areas of drug delivery, diagnostics and cell and tissue engineering. Edward J. Ludwig has been the chief executive officer of Becton, Dickinson for more than six years. He has been with the health care and services company for over 27 years. Ludwig earned a BA from the College of Holy Cross, and a MBA from Columbia University. Beckton, Dickinson & Company maintains its headquarters in the United States and has offices in nearly 50 countries worldwide.

Icell Gene Therapeutics LLC, located in Stony Brook, NY, is dedicated to the development of innovative gene therapies through its collaboration with NeoMatrix Therapeutics. The company focuses on advancing its therapeutic pipeline, which includes targeted molecular therapies designed to address various complex health conditions. With a team of experienced professionals, Icell Gene Therapeutics emphasizes strategic partnerships to enhance its research and development capabilities. The company is committed to transforming healthcare by harnessing cutting-edge genetic technologies to improve patient outcomes. Generated from the website

Revvity in Shelton, a division of PerkinElmer, empowers scientists, researchers, and clinicians to tackle their most pressing issues in science and healthcare. They offer innovative solutions for diagnostics, life sciences, food, and applied markets. With a focus on addressing critical challenges, Revvity in Shelton provides cutting-edge tools and technologies to drive advancements in various industries. Their commitment to excellence and innovation sets them apart as a leader in the field. Generated from their website's infomation